comparemela.com

Latest Breaking News On - Optical services - Page 3 : comparemela.com

Surgery Partners (NASDAQ:SGRY) Now Covered by StockNews com

Analysts at StockNews.com assumed coverage on shares of Surgery Partners (NASDAQ:SGRY – Get Rating) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the stock. SGRY has been the subject of a number of other reports. JPMorgan Chase & Co. reduced their target price on shares of Surgery Partners […]

Landscape Capital Management L L C Invests $269,000 in Surgery Partners, Inc (NASDAQ:SGRY)

Landscape Capital Management L.L.C. purchased a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 9,649 shares of the company’s stock, valued at approximately $269,000. Several other institutional investors have also […]

Bradley R Owens Sells 7,191 Shares of Surgery Partners, Inc (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) insider Bradley R. Owens sold 7,191 shares of the firm’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $36.31, for a total value of $261,105.21. Following the completion of the sale, the insider now directly owns 74,189 shares in […]

Surgery Partners (NASDAQ:SGRY) Earns Buy Rating from Analysts at Mizuho

Mizuho began coverage on shares of Surgery Partners (NASDAQ:SGRY – Get Rating) in a research report sent to investors on Friday, The Fly reports. The firm issued a buy rating and a $48.00 price target on the stock. Other equities research analysts have also issued research reports about the company. Benchmark reissued a buy rating […]

Surgery Partners (NASDAQ:SGRY) Upgraded to Hold at StockNews com

StockNews.com upgraded shares of Surgery Partners (NASDAQ:SGRY – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday. Other analysts also recently issued research reports about the company. JPMorgan Chase & Co. cut their price target on Surgery Partners from $45.00 to $40.00 and set a neutral […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.